PHOENIX, Ariz -- November 15, 2010 -- House dust mite (HDM)-induced asthma has been shown to be responsive to sublingual immunotherapy (SLIT) in one of the first, large SLIT-controlled studies performed in China, researchers reported here at the 2010 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI).
In fact, "patients with moderate asthma have more than twice the chance to be either well controlled or totally controlled with SLIT than with a placebo," noted lead investigator Jian Yin, MD, Peking University Medical College Hospital, Beijing, China.
Dr. Yin and his team reported here on November 14 that SLIT can be used successfully without adverse events and with good overall safety in adult patients with moderate, persistent asthma attributable to HDM, based on the results of their double-blind, placebo-controlled study. The team screened 699 patients from 14 clinics throughout China and separated 484 of them into 2 groups: 308 active and 157 placebo.
http://www.docguide.com/news/content.nsf/news/852576140048867C852577DC00752FE6?OpenDocument&c=&count=10&id=48DDE4A73E09A969852568880078C249
Subscribe to:
Post Comments (Atom)
Mother and daughter getting allergy skin tests. Click on the photo to see a You Tube interview with another parent and child.
No comments:
Post a Comment